Abstract
ObjectiveTo assess the impact of glycemic control in gestational on neonatal weight and metabolic complications of twin and singleton pregnancies. MethodsAn observational, retrospective study to monitor 120 twin and 240 singleton pregnancies in women with GDM. Maternal glycemic parameters during pregnancy (oral glucose tolerance test results, treatment, insulinization rate, mean HbA1c in the third trimester), and neonatal complications and weight were recorded. ResultsA higher infant birth weight ratio (IBWR 1.02±0.12 vs. 0.88±0.12, p<0.001) and a lower rate of newborns small for gestational age (severe SGA 2.5% vs. 8.3%, p=0.012) were seen after singleton pregnancies as compared to twin pregnancies. The rates of newborns large for gestational age (LGA 12.6% vs. 12.5%, p=0.989); macrosomic (6.7% vs. 7.5%, p=0.777); or small for gestational age (SGA 6.7% vs. 10.8%, p=0.175) were similar in both groups. Neonates from twin pregnancies had a higher risk of hypoglycemia (adjusted OR 4.71; 1.38–16.07, p=0.013) and polycythemia (adjusted OR 10.05; 1.82–55.42, p=0.008). A linear relationship was seen between third trimester HbA1c levels and IBWR in singleton (r=.199, p=0.003), but not in twin pregnancies (r=0.049, p=0.610). ConclusionsRisk of severe SGA, hypoglycemia, and polycythemia was significantly higher in twin pregnancies of women with GDM. Neonatal weight outcomes and metabolic complications in twin pregnancies of women with GDM were not related to glycemic control. Moreover, in our study population, fasting glucose at diagnosis and mean HbA1c in the third trimester showed a linear relationship with higher birth weights in singleton, but not in twin pregnancies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have